In 1999, officials reported the first cases of West Nile Virus (WNV) in North America in eight New York City patients. Baxter Healthcare scientist Thomas Kreil realized that sera from infected patients might protect others by passive immunization. The map above, adapted from the CDC, shows how quickly the virus spread west over the next four years. Human cases, usually asymptomatic, followed reports of animal infections. Serum pools collected from areas with high infection rates would have more anti-WNV antibodies. Read more about Kreil's experiments to test his hypothesis in this month's issue.
Passive immunization and West Nile Virus
var FO = { movie:"http://images.the-scientist.com/supplementary/flash/53924/53924.swf", width:"520", height:"410", majorversion:"8", build:"0", xi:"true"}; UFO.create(FO, "ufoDemo"); Passive immunization and West Nile Virus By Edyta Zielinska In 1999, officials reported the first cases of West Nile Virus (WNV) in North America in eight New York City patients. Baxter Healthcare scientist Thomas Kreil realized that sera from infected patients might prote
| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Interested in reading more?
Become a Member of
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Meet the Author
Edyta Zielinska
This person does not yet have a bio.View full profile
Published In
Share
